Your browser doesn't support javascript.
loading
Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma.
Bassil, Emmanuel; Singh, Harjinder; Ahmed, Omair; Parikh, Shamik.
Afiliação
  • Bassil E; Internal Medicine, Henry Ford Allegiance, Jackson, USA.
  • Singh H; Internal Medicine, Henry Ford Allegiance, Jackson, USA.
  • Ahmed O; Internal Medicine, Henry Ford Allegiance, Jackson, USA.
  • Parikh S; Internal Medicine, Henry Ford Allegiance, Jackson, USA.
Cureus ; 15(6): e40089, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37425586
ABSTRACT
Myocardial infarction in young individuals has unique risk factors compared to the older population. Along with usual risk factors, one should explore causes such as recreational drug use, medication-induced myocardial infarction, and spontaneous coronary artery dissection. Here, we present the case of a 32-year-old male who presented with chest pain and was found to have complete thrombotic occlusion of the right coronary artery. He recently started receiving chemotherapy with bleomycin, etoposide, and cisplatin (PEB). In the absence of other risk factors and previous reports of similar cardiotoxicity with bleomycin, the patient was deemed to have an adverse effect from the chemotherapy regimen.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
...